Results 81 to 90 of about 966,359 (290)

Epidemiology of Clostridium Difficile Infection [PDF]

open access: yesDeutsches Ärzteblatt international, 2015
According to L¨bbert et al., the incidence of Clostridium difficile infection (CDI) in Germany is 5 to 20 cases per 100 000 persons (1). It can be assumed that this figure is much too low. An ecological study based on routine data identified a total of 9874 cases hospitalized because of CDI, as well as further 26 341 cases with CDI as a concomitant ...
openaire   +2 more sources

Incidence and surveillance of infections from Clostridium difficile: the experience at the Galliera of Genoa in the three-year period 2004-2006

open access: yesMicrobiologia Medica, 2009
Introduction Clostridium difficile is a Gram-positive bacillus, anaerobic, sporogenous ,with oro-faecal transmission.The formation of the spores can persist in a long time, encouraging the transmission.
David Usiglio   +10 more
doaj   +1 more source

Treatment of Clostridium difficile infection [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 1998
The treatment options for Clostridium difficile infection remain limited, although promising agents are currently being assessed. Metronidazole is the first-line drug of choice for those patients requiring specific anti-C. difficile treatment. Much of the interest in alternative therapies has centred on the difficult management issues posed by patients
openaire   +2 more sources

A study of Clostridium difficile in biofilm mode of growth using the Sorbarod filter system [PDF]

open access: yes
In all ecosystems, bacteria are likely to grow in biofilms, and the organisms making up the natural flora of the colon are considered to be no exception to this. One of the most important hospital-acquired infections is antibiotic associated diarrhoea,
O'Connell, Nuala H.
core  

Investigation into the mobile genetic elements of Clostridium difficile [PDF]

open access: yes, 2013
Clostridium difficile is a pathogenic bacterium that can colonise both humans and various animals. Toxin production leads to clinical symptoms ranging from mild to severe diarrhoea and can result in potentially fatal pseudomembranous colitis.
Brouwer, MSM
core  

Infection Clostridium difficile as increasing epidemiological issue

open access: yesJournal of Education, Health and Sport, 2017
Introduction: Clostridium difficile as an infectious agent of pseudomembranous enterocolitis, becomes more and more frequent problem among health facilities.
Maciej Rutkowski   +3 more
doaj   +3 more sources

Using Synthetic Glycans to Investigate Anti‐Glycan Antibodies and Explore Their Medical Potential

open access: yesAngewandte Chemie International Edition, EarlyView.
Anti‐glycan antibodies are essential in health and disease. Access to novel glycan structures paves the way for progress in antibody profiling for biomarker discovery, antibody development, and vaccine design. We summarize the strategies to synthesize and utilize synthetic glycans for the development and application of anti‐glycan antibodies in basic ...
Fabienne Weber   +4 more
wiley   +1 more source

Epidemiology and predictors of 30-day mortality in clinically significant Clostridium species infections

open access: yesDiscover Medicine
Purpose Clostridium species are an under-recognized cause of severe infections with substantial mortality, yet national data remain limited. This study aimed to characterize the epidemiological, microbiological, clinical, and therapeutic features of ...
Ana Gorgulho   +8 more
doaj   +1 more source

Heat Stress and Gut Microbiome Dynamics in Poultry: Interplay, Consequences, and Mitigation Strategies

open access: yesAnimal Research and One Health, EarlyView.
Heat stress disrupts gut microbial balance in poultry, impairing nutrient absorption and immunity. This review outlines the interplay between thermal stress and microbiome dynamics and discusses integrative mitigation strategies, probiotics, phytogenics, cooling systems, and genetic adaptation to enhance poultry resilience.
O. E. Oke   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy